The Impact of the CTHRSSVVC Peptide Upon Experimental Models of Trypanosoma cruzi Infection
Chagas disease (CD), caused by the hemoflagellate protozoan Trypanosoma cruzi, affects more than six million people worldwide and presents an unsatisfactory therapy, based on two nitroderivatives, introduced in clinical medicine for decades. The synthetic peptide, with CTHRSSVVC sequence (PepA), mim...
Main Authors: | Gabriela Rodrigues Leite, Denise da Gama Jaén Batista, Ana Lia Mazzeti, Rosemeire Aparecida Silva, Ademar Benévolo Lugão, Maria de Nazaré Correia Soeiro |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2022.882555/full |
Similar Items
-
Trypanosoma cruzi antigen detection in blood to assess treatment efficacy and cure in mice models of Chagas disease
by: Fernanda Fortes de Araujo, et al.
Published: (2024-01-01) -
The biological in vitro effect and selectivity of aromatic dicationic compounds on Trypanosoma cruzi
by: Cristiane França da Silva, et al.
Published: (2010-05-01) -
Hallmarks of the relationship between host and Trypanosoma cruzi sulfated glycoconjugates along the course of Chagas disease
by: Luciana L. Soprano, et al.
Published: (2023-05-01) -
Canine Macrophage DH82 Cell Line As a Model to Study Susceptibility to Trypanosoma cruzi Infection
by: Pedro Henrique Braz Mendonça, et al.
Published: (2017-05-01) -
Seroprevalence of Trypanosoma cruzi infection in blood donors in the extreme South of Brazil
by: Tanise Freitas Bianchi, et al.
Published: (2022-04-01)